INTERCEPT PHARMACEUTICALS, INC.·4

Nov 16, 7:00 PM ET

Sullivan Ryan T 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Nov 16, 2020

Insider Transaction Report

Form 4
Period: 2020-11-13
Sullivan Ryan T
General Counsel
Transactions
  • Tax Payment

    Common Stock

    2020-11-13$37.87/sh493$18,67024,708 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person.

Documents

1 file
  • 4
    tm2036091d2_4.xmlPrimary

    OWNERSHIP DOCUMENT